Abstract LB277: Exposure Response and Safety Analysis of Osimertinib in Combination with Pemetrexed and Platinum-Based Chemotherapy for the First-Line Treatment of Locally Advanced or Metastatic NSCLC Patients with EGFRm (FLAURA2)
Cancer Research（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined